Date post: | 28-Feb-2018 |
Category: |
Documents |
Upload: | rudy-langi |
View: | 215 times |
Download: | 0 times |
of 27
7/25/2019 Statistical Treatment and Tables_SPC Research
1/27
Group Type of Card PHARMACY BRANCH Gender Age
1 With reward One Fai!y Ma!e "#
$ With reward One Fai!y Fea!e $%
# With reward One Fai!y Ma!e #1
% With reward One Fai!y Ma!e $&
' With reward One Fai!y Fea!e #$
" With reward One Fai!y Fea!e $(( With reward One Fai!y Fea!e $1
) With reward One Fai!y Ma!e ')
& With reward One Fai!y Fea!e #(
1* With reward One Fai!y Ma!e 1&
11 With reward One Fai!y Fea!e %&
1$ With reward One Fai!y Ma!e "%
1# With reward One Fai!y Fea!e %*
1% With reward One Fai!y Fea!e 1)
1' With reward One Fai!y Fea!e "#
1" With reward +u,re! Ma!e $&1( With reward +u,re! Fea!e $1
1) With reward +u,re! Fea!e "$
1& With reward +u,re! Ma!e $%
$* With reward +u,re! Fea!e $"
$1 With reward +u,re! Fea!e #*
$$ With reward +u,re! Fea!e $(
$# With reward +u,re! Fea!e '$
$% With reward +u,re! Fea!e %"
$' With reward +u,re! Fea!e '#
$" With reward +u,re! Fea!e '*
$( With reward +u,re! Fea!e $&
$) With reward +u,re! Ma!e #"
$& With reward +u,re! Ma!e #1
#* With reward +u,re! Ma!e $'
1 Without reward Boti-a Hanoi Fea!e $"
$ Without reward Boti-a Hanoi Fea!e $)
# Without reward Boti-a Hanoi Fea!e $%
% Without reward Boti-a Hanoi Ma!e $&
' Without reward Boti-a Hanoi Fea!e '&
" Without reward Boti-a Hanoi Fea!e 1)
( Without reward Boti-a Hanoi Fea!e $1
) Without reward Boti-a Hanoi Fea!e $)
& Without reward Boti-a Hanoi Fea!e $(
1* Without reward Boti-a Hanoi Fea!e $"
11 Without reward Boti-a Hanoi Ma!e "*
1$ Without reward Boti-a Hanoi Ma!e %)
1# Without reward Boti-a Hanoi Ma!e $&
1% Without reward Boti-a Hanoi Fea!e $'
7/25/2019 Statistical Treatment and Tables_SPC Research
2/27
1' Without reward Boti-a Hanoi Fea!e '(
1" Without reward Beu.ie Ma!e $"
1( Without reward Beu.ie Fea!e #&
1) Without reward Beu.ie Fea!e #%
1& Without reward Beu.ie Ma!e $(
$* Without reward Beu.ie Fea!e $$
$1 Without reward Beu.ie Fea!e ##$$ Without reward Beu.ie Ma!e "1
$# Without reward Beu.ie Fea!e ")
$% Without reward Beu.ie Fea!e 1&
$' Without reward Beu.ie Fea!e '%
$" Without reward Beu.ie Fea!e $%
$( Without reward Beu.ie Fea!e %(
$) Without reward Beu.ie Fea!e $)
$& Without reward Beu.ie Fea!e #*
#* Without reward Beu.ie Ma!e $"
7/25/2019 Statistical Treatment and Tables_SPC Research
3/27
Pre/0a!e Pot2a!e Pre2tore.iit Pot2tore Preyo Carditt
$%13'* ''#3** ' 1* 1 *
&'#3%* 14(*&3** 1) #* 1 *
1$*3$* ""13** $ 1* 1 *
#1(3$* )##3** % 1* 1 *
)(13## 14#"%3(' 1% $* 1 *
14$"(3"( $4*)13'* $* #* 1 * 14''(3)( $4$%$3** $# #* 1 *
#113*% (&%3'* ' 1$ 1 *
''3** 11)3** 1 $ 1 *
)1'3$' 14$$(3** 1' $* 1 *
&1(3$' 14"*)3(' 1$ $* 1 *
"%%3(* &"13** ( 1* 1 *
14')#3## $4')'3** $* #* 1 *
#1#3'% )1$3'* ' 1$ 1 *
14*#13$' 14%''3** 1' $* 1 *
14#()3)* $4%%)3** 1) #* 1 * 14#%*3** $4*($3** $* $& 1 *
$')3"( %#*3** % " 1 *
1(%3"* "$$3** # 1* 1 *
14*"(3(# 14($*3** 1' $$ 1 *
($(3$* 14#1$3** 1$ $* 1 *
14*&'3** 14&('3** 1' $' 1 *
#*13"( (&"3** ' 1$ 1 *
14#')3"( $4$%)3** $* #* 1 *
14(**3"( $4("13** $* #* 1 *
14")13"* $4$'$3** $% #* 1 *
"'(3'* 14#&'3** 1* $* 1 *
#1131' ))(3** ' 1# 1 *
#'*3** ("*3** ' 1* 1 *
##$3*) ))13** ' 1$ 1 *
"&)3** "&*3** ) 11 * 1
##%3** #$%3** ' " * 1
"%13** "$'3** ) 1* * 1
'$$3** )##3** ' 1* * 1
)1*3** )**3** 1* 1$ * 1
14$'"3** 14$$)3** 1% 1" * 1
''$3** '%(3** ' ( * 1
)113** )*$3** & 11 * 1
##(3** ##$3** ' ' * 1
)1"3** )*"3** 1* 11 * 1
)%13** )$"3** 1' 1% * 1
)(&3** )'&3** 1* 1* * 1
%"*3** %'*3** ' " * 1
"*$3** ')$3** 1* ) * 1
7/25/2019 Statistical Treatment and Tables_SPC Research
4/27
$%#3** $##3** ' % * 1
14##%3** 14#&%3** $* $* * 1
14$$%3** 14$()3** 1) $$ * 1
141**3** 141&*3** 1) $$ * 1
14%)#3** 14')#3** $' #* * 1
14$&(3** 14#((3** $* $* * 1
14"#13** 14"&13** $* $" * 1 14#"(3** 14%*(3** $* $# * 1
14%1"3** 14%&"3** $* $% * 1
14$''3** 14$(#3** 1) $* * 1
14(")3** 14)")3** $' #* * 1
14&)$3** $4*$)3** $# #* * 1
$"13** $)13** ' ' * 1
14##&3** 14%113** 1) $* * 1
14"*"3** 14"'"3** $' #* * 1
"#(3** "'$3** ' 1* * 1
7/25/2019 Statistical Treatment and Tables_SPC Research
5/27
51 5$ 5#A 5#B 5#C 5#6
1 * * * * 1
* * * * * 1
1 1 * * * *
1 * * * 1 *
1 1 * * * *
1 1 * * * ** 1 * * * 1
* 1 * 1 1 1
1 * * * * 1
1 1 * * * *
1 1 * * * *
1 1 * * * *
* * * * * 1
* * * * * 1
1 1 * * * *
1 1 * * * *1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
* * * 1 * *
1 1 * * * *
1 1 * * * *
1 1 * * * *
* * * 1 * *
* * * * * 1
* * * * * 1
* * * * * 1
1 * * * * 1
* * 1 1 1 *
* * * * * 1
* * * * * 1
* * * * * 1
* * * * * 1
* * * * * 1
* * * * * 1
* * * * * 1
* * 1 * * 1
* * * * * 1
7/25/2019 Statistical Treatment and Tables_SPC Research
6/27
* * 1 * * 1
* * * * * 1
* * * * * 1
1 1 * * * *
1 1 * * * *
* * * * * *
1 * * * 1 ** * * * * *
1 * * 1 * 1
* * * * * *
* * 1 1 1 1
* * 1 * * 1
1 1 * * * *
* * * * * 1
* * * * * 1
* * 1 * * *
7/25/2019 Statistical Treatment and Tables_SPC Research
7/27
Group Pre Pot
1 ' 1*
1 1) #*
1 $ 1*
1 % 1*1 1% $*
1 $* #*
1 $# #*
1 ' 1$
1 1 $
1 1' $*
1 1$ $*
1 ( 1*
1 $* #*
1 ' 1$1 1' $*
1 1) #*
1 $* $&
1 % "
1 # 1*
1 1' $$
1 1$ $*
1 1' $'
1 ' 1$
1 $* #*
1 $* #*
1 $% #*
1 1* $*
1 ' 1#
1 ' 1*
1 ' 1$
$ ) 11
$ ' "
$ ) 1*
$ ' 1*
$ 1* 1$
$ 1% 1"
$ ' (
$ & 11
$ ' '
$ 1* 11
$ 1' 1%
$ 1* 1*
7/25/2019 Statistical Treatment and Tables_SPC Research
8/27
$ ' "
$ 1* )
$ ' %
$ $* $*
$ 1) $$
$ 1) $$
$ $' #*$ $* $*
$ $* $"
$ $* $#
$ $* $%
$ 1) $*
$ $' #*
$ $# #*
$ ' '
$ 1) $*
$ $' #*$ ' 1*
7/25/2019 Statistical Treatment and Tables_SPC Research
9/27
Pre Tet Pot Tet
Contro! Treatent Contro! Treatent
Count #* #* #* #*
Mean 1#3%( 113'( 1'3(( 1)3)#
0tandard 6e.iation (31( (31) )3'1 )3)&Ma7iu $'3** $%3** #*3** #*3**
5# $*3** 1)3** $$3** $&3('
Median 1$3** 1$3** 1#3** $*3**
51 '3(' '3** 1*3** 1*3'*
Miniu '3** 13** %3** $3**
Contro! Treatent Contro! Treatent
Botto '3(' '3** 1*3** 1*3'*
$5Bo7 "3$' (3** #3** &3'*
#58o7 )3** "3** &3** &3('Whi9er / *3(' %3** "3** )3'*
Whi9er : '3** "3** )3** *3$'
7/25/2019 Statistical Treatment and Tables_SPC Research
10/27
7/25/2019 Statistical Treatment and Tables_SPC Research
11/27
Group Pre Pot
1 $%13'* ''#3**
1 &'#3%* 14(*&3**
1 1$*3$* ""13**
1 #1(3$* )##3**1 )(13## 14#"%3('
1 14$"(3"( $4*)13'*
1 14''(3)( $4$%$3**
1 #113*% (&%3'*
1 ''3** 11)3**
1 )1'3$' 14$$(3**
1 &1(3$' 14"*)3('
1 "%%3(* &"13**
1 14')#3## $4')'3**
1 #1#3'% )1$3'*1 14*#13$' 14%''3**
1 14#()3)* $4%%)3**
1 14#%*3** $4*($3**
1 $')3"( %#*3**
1 1(%3"* "$$3**
1 14*"(3(# 14($*3**
1 ($(3$* 14#1$3**
1 14*&'3** 14&('3**
1 #*13"( (&"3**
1 14#')3"( $4$%)3**
1 14(**3"( $4("13**
1 14")13"* $4$'$3**
1 "'(3'* 14#&'3**
1 #1131' ))(3**
1 #'*3** ("*3**
1 ##$3*) ))13**
$ "&)3** "&*3**
$ ##%3** #$%3**
$ "%13** "$'3**
$ '$$3** )##3**
$ )1*3** )**3**
$ 14$'"3** 14$$)3**
$ ''$3** '%(3**
$ )113** )*$3**
$ ##(3** ##$3**
$ )1"3** )*"3**
$ )%13** )$"3**
$ )(&3** )'&3**
7/25/2019 Statistical Treatment and Tables_SPC Research
12/27
$ %"*3** %'*3**
$ "*$3** ')$3**
$ $%#3** $##3**
$ 14##%3** 14#&%3**
$ 14$$%3** 14$()3**
$ 141**3** 141&*3**
$ 14%)#3** 14')#3**$ 14$&(3** 14#((3**
$ 14"#13** 14"&13**
$ 14#"(3** 14%*(3**
$ 14%1"3** 14%&"3**
$ 14$''3** 14$(#3**
$ 14(")3** 14)")3**
$ 14&)$3** $4*$)3**
$ $"13** $)13**
$ 14##&3** 14%113**
$ 14"*"3** 14"'"3**$ "#(3** "'$3**
7/25/2019 Statistical Treatment and Tables_SPC Research
13/27
Pre Tet Pot Tet
Contro! Treatent Contro! Treatent
Count #* #* #* #*
Mean &)#3%* (&13$* 1*1(3%* 1#)'3'*
0tandard 6e.iation %)13&( '$*3)% '*'3'* (1&3"%Ma7iu 1&)$3** 1(**3"( $*$)3** $("13**
5# 1##(3(' 1$$%3'* 1%*#3(' $*%(3('
Median )"*3** ((13$# )%"3** 1##)3#)
51 "1*3(' #113(' "#13(' )**31#
Miniu $%#3** ''3** $##3** 11)3**
Contro! Treatent Contro! Treatent
Botto "1*3(' #113(' "#13(' )**31#
$5Bo7 $%&3$' %'&3%( $1%3$' '#)3$'
#58o7 %((3(' %'#3$) ''(3(' (*&3#)Whi9er / #"(3(' $'"3(' #&)3(' ")$31#
Whi9er : "%%3$' %("31( "$%3$' (1#3$'
7/25/2019 Statistical Treatment and Tables_SPC Research
14/27
7/25/2019 Statistical Treatment and Tables_SPC Research
15/27
6ata
Gender A.erage / Pre2tore.iit A.erage / Pot2tore.iitFea!e 1#3&'1$1&'1$$ 1)3(#1(*(#1(1Ma!e &3%$1*'$"#1" 1%3$1*'$"#1')
Total Result 12.5166666667 17.3
Gender / a!! /
6ataAge A.erage / Pre2tore.iit A.erage / Pot2tore.iit1)/$( 1#3%()$"*)"&" 1)31(#&1#*%#'
$)/#( 1*3#'$&%11("' 1'3"%(*'))$#'
#)/%( 1'3(' $13('%)/'( 1%3%$)'(1%$)" 1&3%$)'(1%$)"')/") 113$$$$$$$$$$ 1%3'''''''''"
Total Result 12.5166666667 17.3
6ataType of Card A.erage / Pre2tore.iit A.erage / Pot2tore.iit
With reward 113'""""""""( 1)3)#########Without reward 1#3%""""""""( 1'3(""""""""(
Total Result 12.5166666667 17.3
6ataPHARMACY BRA A.erage / Pre2tore.iit A.erage / Pot2tore.iitBeu.ie 1)3"""""""""( $$31#########
Boti-a Hanoi )3$""""""""( &3%
+u,re! 1$3*""""""""( 1&3########One Fai!y 113*""""""""( 1(3(#########
Total Result 12.5166666667 17.3
Fee! -oforta8!e 8uying at thi phara-y6ata
5#6 A.erage / Pre2tore.iit A.erage / Pot2tore.iit
* 1$3)%#(' 1)3&")('
1 1$31%$)'(1%$& 1'3#&$)'(1%$&
;i.e near the area
6ata5#A A.erage / Pre2tore.iit A.erage / Pot2tore.iit* 1$3'''''''''" 1(3'1)'1)'1)'
1 1$31""""""""( 1'3##########
Pri-e are -heaper
6ata5#B A.erage / Pre2tore.iit A.erage / Pot2tore.iit* 1$3$'&$'&$' 1(
1 1%3)######### $*
-!oe re!ationhip with the Phara-it < a!e ta=
6ata5#C A.erage / Pre2tore.iit A.erage / Pot2tore.iit
* 1$3%&*&*&*&*& 1(3$#"#"#"#"%
1 1$3) 1)
7/25/2019 Statistical Treatment and Tables_SPC Research
16/27
6ata
Gender A.erage / Pre/0a!e A.erage / Pot2a!eFea!e 14#*#3(&Ma!e "')3&$ &)*3"1
Total Result 887.30 1,201.45
Gender / a!! /
6ataAge A.erage / Pre/0a!e A.erage / Pot2a!e1)/$( &%)31% 14$#(3#'
$)/#( (%*3"( 14*""3)1
#)/%( 141*"3(' 14'&)3**%)/'( 14*(*31( 14%)$3'%')/") ("&3*$ &"&31(
Total Result 887.30 1,201.45
6ataType of Card A.erage / Pre/0a!e A.erage / Pot2a!e
With reward (&13$* 14#)'3'*Without reward &)#3%* 14*1(3%*
Total Result 887.30 1,201.45
6ataPHARMACY BRA A.erage / Pre/0a!e A.erage / Pot2a!eBeu.ie 14#1#3## 14#($3##
Boti-a Hanoi "'#3%( ""$3%(
+u,re! )%&3*$ 14'*#3One Fai!y (##3#( 14$"(3*(
Total Result 887.30 1,201.45
Fee! -oforta8!e 8uying at thi phara-y6ata
5#6 A.erage / Pre/0a!e A.erage / Pot2a!e
* )&$3'% 14#%#3&1
1 ))13#1 14*#)3"%
;i.e near the area
6ata5#A A.erage / Pre/0a!e A.erage / Pot2a!e* )("3"# 14$$#3$"
1 &)#3## 14**'31(
Pri-e are -heaper
6ata5#B A.erage / Pre/0a!e A.erage / Pot2a!e* )")3)( 141)'31*
1 14*'#31$ 14#%)3')
-!oe re!ationhip with the Phara-it < a!e ta=
6ata5#C A.erage / Pre/0a!e A.erage / Pot2a!e
* ))*3*1 14$*13)#
1 &"(3%' 141&(3#*
7/25/2019 Statistical Treatment and Tables_SPC Research
17/27
Ano.a> Two/Fa-tor With Rep!i-ation
0?MMARY Pre Pot Tota!
1
Count #* #* "*
0u #%( '"' &1$
A.erage 113'""""( 1)3)#### 1'3$@arian-e '13%&'%*$ (&31*&$ ((3"$*#%
2
Count #* #* "*
0u %*% %(# )((
A.erage 1#3%""""( 1'3("""( 1%3"1""(
@arian-e '13#"*&$ ($3%"*&$ "$3$*"'
Total
Count "* "*0u ('1 1*#)
A.erage 1$3'1"""( 1(3#
@arian-e '13%(%$&% ("3)&1'#
ANO@A
Source of Variation SS df MS F
Group Treatent / Contro! 1*3$1 1 1*3$1 *31"
Change Pre/Pot ")"3%1 1 ")"3%1 1*3(&
ntera-tion 1)'3*1 1 1)'3*1 $3&1Within (4#()3#( 11" "#3"1
Tota! )4$'&3&& 11&
7/25/2019 Statistical Treatment and Tables_SPC Research
18/27
Pre Pot
Treatent 113" 1)3)
Contro! 1#3' 1'3)
P-value F crit
*3"& #3&$
*3** #3&$
*3*& #3&$
Pre*3*
'3*
1*3*
1'3*
$*3*
Average store visits, Treatment vs Control Grou
Treatent Contro!
Contro! Treatent
*3**
'3**
1*3**
1'3**
$*3**
$'3**
#*3**
#'3**
re!e"periment #tore $isits
%o. o& $isits
Contro! Treatent
*3**
'3**
1*3**
1'3**
$*3**
$'3**
#*3**
#'3**
ost!e"periment #tore $isits
%o. o& visits
7/25/2019 Statistical Treatment and Tables_SPC Research
19/27
Pot
ps
7/25/2019 Statistical Treatment and Tables_SPC Research
20/27
Ano.a> Two/Fa-tor With Rep!i-ation
0?MMARY Pre Pot Tota!
1
Count #* #* "*
0u $#4(#'3)" %14'"'3** "'4#**3)"
A.erage (&13$* 14#)'3'* 14*))3#'@arian-e $(14$"&3#" '1(4)))3"* %((4")(3#'
2
Count #* #* "*
0u $&4'*$3** #*4'$$3** "*4*$%3**
A.erage &)#3%* 14*1(3%* 14***3%*
@arian-e $#$4$&&31% $''4'$"3)* $%*4*($3('
Total
Count "* "*0u '#$#(3)'"11))) ($*)(
A.erage ))(3$&("*1&)1% 1$*13%'
@arian-e $'"&*)3$$%$' %1%"*13)("(
ANO@A
Source of Variation SS df MS
0ap!e $#$4*%#3%$ 1 $#$4*%#3%$
Co!un $4&"*4('13)) 1 $4&"*4('13))
ntera-tion $4#'%4'"*3&) 1 $4#'%4'"*3&)Within #(4*#$4'##3#$ 11" #1&4$%'3&)
Tota! %$4'(&4))&3"* 11&
7/25/2019 Statistical Treatment and Tables_SPC Research
21/27
PreTet PotTet
Treatent (&131&'$ 1#)'3'
Contro! &)#3% 1*1(3%
F P-value F crit
*3($( *3#&" #3&$#
&3$(% *3**# #3&$#
(3#(' *3**) #3&$#
PreTet*
$**
%**
"**
)**
1***
1$**
1%**
1"**
Average pur'(ases, Treatment vs Co
Treatent Co
Contro!
*3**
$**3**
%**3**
"**3**
)**3**
1***3**
1$**3**
1%**3**
1"**3**
re!e"periment ur'(ases per re
#ales
7/25/2019 Statistical Treatment and Tables_SPC Research
22/27
PotTet
ntrol Groups
ntro!
Treatent
pon)ent
Contro!
*3**
'**3**
1***3**
1'**3**
$***3**
$'**3**
oste"periment pur'(ases per respon)e
#ales
7/25/2019 Statistical Treatment and Tables_SPC Research
23/27
Treatent
t
7/25/2019 Statistical Treatment and Tables_SPC Research
24/27
Nae Pre/a!e Pot/a!e Pre/.iit Pot/.iit
13 A-o!a-o!4 Fe!i7 A-o!a-o!4 F3 $%13'* ''#3** ' 1*
$3 Ca8a!!e4 Apri! Ca8a!!e4 A3 #1#3'% )1$3'* ' 1$
#3 C!ori8e!4 Aor C!ori8e!4A3 14')#3## $4')'3** $* #*
%3 Co4 A!e7ander Co4 A3 "%%3(* &"13** ( 1*
'3 6a-!an4 Marite 6a-!an4 M3 &1(3$' 14"*)3(' 1$ $*
"3 Fide!4 +Day Fide!4 +3 )1'3$' 14$$(3** 1' $*(3 Gon,aga4 Wi!!yn Gon,aga4 W3 ''3** 11)3** 1 $
)3 Hernando4 Eeue! Hernando4 E3 #113*% (&%3'* ' 1$
&3 anio!a4 Miyu9i anio!a4 M3 14''(3)( $4$%$3** $# #*
1*3 ;oa4 Gena ;oa4 G3 14$"(3"( $4*)13'* $* #*
113 MeDo4 Roe MeDo4 R3 )(13## 14#"%3(' 1% $*
1$3 Poduna4 F!oren-ia Poduna4 F3 14*#13$' 14%''3** 1' $*
1#3 0antiane4 ;!oyd 0antiane4 ;3 #1(3$* )##3** % 1*
1%3 ntong4 Phi!ip ntong4 P3 1$*3$* ""13** $ 1*
1'3 0u8radi!4 G!ady 0u8radi!4 G3 &'#3%* 14(*&3** 1) #*
13 oro!an4 A!!an oro!an4 A3 14#()3)* $4%%)3** 1) #*$3 Po!inar4 Ara-e!i Po!inar4 A3 14#')3"( $4$%)3** $* #*
#3 +pina4 Nenita +pina4 N3 14(**3"( $4("13** $* #*
%3 Canada4 ;eonita Caada4 ;3 14")13"* $4$'$3** $% #*
'3 5uiton4 ;ho.e!yn 5uiton4 ;3 "'(3'* 14#&'3** 1* $*
"3 Fernande,4 aie Fernande,4 3 #1131' ))(3** ' 1#
(3 A!igato4 ;eo A!igato4;3 #'*3** ("*3** ' 1*
)3 A8ar-a4 etony A8ar-a4 3 ##$3*) ))13** ' 1$
&3 Mur-ia4 rene Mur-ia4 3 14#%*3** $4*($3** $* $)
1*3 Ca8orte4 +7a!ta-ion Ca8orte4 +3 $')3"( %#*3** % "
113 A8ine4 +don A8ine4 +3 1(%3"* "$$3** # 1*
1$3 ;ope,4 Cherie! ;ope,4 C3 14*"(3(# 14($*3** 1' $$
1#3 @iri,4 Ange!a @iri,4 A3 ($(3$* 14#1$3** 1$ $*
1%3 Hipang4 ona!yn Hipang4 3 14*&'3** 14&('3** 1' $'
1'3 Carreon4 Minda Carreon4 M3 #*13"( (&"3** ' 1$
13 a8agat4 Yen a8agat4Y3 "&)3** "&*3** ) 11
$3 Gautin4 +!gen Gautin4 +3 ##%3** #$%3** ' "
#3 C!eente4 6ani-a C!eente4 63 "%13** "$'3** ) 1*
%3 0antiane4 ;!oyd 0antiane4 ;3 '$$3** '1$3** ' (
'3 0i8aDan4 Caren 0i8aDan4 C3 )1*3** )**3** 1* 1$
"3 Beri,o4 Ange! Beri,o4 A3 14$'"3** 14$$)3** 1% 1"
(3 anio!a4 Miyu9i Miyu9i4 3 ''$3** '%(3** ' (
)3 Baynoa4 Rowena Baynoa4 R3 )113** )*$3** & 11
&3 Paon4 6oi-ri Paon4 63 ##(3** ##$3** ' '
1*3 0er.i!!a4 C!ari,e 0er.i!!a4 C3 )1"3** )*"3** 1* 11
113 +!egin4 +dgie +!egin4 +3 )%13** )$"3** 1' 1%
1$3 5uinte4 0erio 5uinte4 03 )(&3** )'&3** 1* 1*
1#3 Buenafe4 oge! Buenafe4 3 %"*3** %'*3** ' "
1%3 Bet!agan4 Honey!yn Bet!agan4 H3 "*$3** ')$3** 1* )
7/25/2019 Statistical Treatment and Tables_SPC Research
25/27
1'3 Mendo,a4 F!oren-ia Mendo,a4 F3 $%#3** $##3** ' %
13 Mag/aoiano4 +dwin Mag/aoano "#(3** "'$3** ' 1*
$3 6oDo4 @angie 6oDo4 @3 14$$%3** 14$()3** 1) $$
#3 Cata!!a4 Ce!ina Catana4 C3 14"*"3** 14"'"3** $' #*
%3 0e-i8an4 Rhea 0e-i8an4 R3 14##&3** 14%113** 1) $*
'3 Tagyaon4 Henry Tagyaan4 H3 14##%3** 14#&%3** $* $*
"3 Ca!i8ag4 ;u-ia Ca!i8ay4 ;3 $"13** $)13** ' '(3 Tero!4 Regin Tero!4 R3 14&)$3** $4*$)3** $# #*
)3 +todi!!o4 +te!a +todi!!o4 +3 14(")3** 14)")3** $' #*
&3 Na.arro4 6ea Na.arro4 63 14$''3** 14$(#3** 1) $*
1*3 Ba!a,ue!a4 F!orenda Ba!a,ue!a4 F3 14%1"3** 14%&"3** $* $%
113 Mag8anua4 Pedrito Mag8anua4 P3 14#"(3** 14%*(3** $* $#
1$3 Conrado4 Bethe! Conrado4 B3 14"#13** 14"&13** $* $"
1#3 Aniue4 Ai!een Aniue4 A3 14$&(3** 14#((3** $* $*
1%3 uaria4 Wi!freda uaria4 W3 141**3** 141&*3** 1) $$
1'3 ?r8i,tondo4 hon r3 ?r8i,tondo4 3 14%)#3** 14')#3** $' #*
7/25/2019 Statistical Treatment and Tables_SPC Research
26/27
Pre/a!e Pot/a!e
A-o!a-o!4 F3 $%13'* ''#3**
0u8radi!4 G3 &'#3%* 14(*&3**
ntong4 P3 1$*3$* ""13**
0antiane4 ;3 #1(3$* )##3**
MeDo4 R3 )(13## 14#"%3('
;oa4 G3 14$"(3"( $4*)13'*anio!a4 M3 14''(3)( $4$%$3**
Hernando4 E3 #113*% (&%3'*
Gon,aga4 W3 ''3** 11)3**
Fide!4 +3 )1'3$' 14$$(3**
6a-!an4 M3 &1(3$' 14"*)3('
Co4 A3 "%%3(* &"13**
C!ori8e!4A3 14')#3## $4')'3**
Ca8a!!e4 A3 #1#3'% )1$3'*
Poduna4 F3 14*#13$' 14%''3**
oro!an4 A3 14#()3)* $4%%)3**Mur-ia4 3 14#%*3** $4*($3**
Ca8orte4 +3 $')3"( %#*3**
A8ine4 +3 1(%3"* "$$3**
;ope,4 C3 14*"(3(# 14($*3**
@iri,4 A3 ($(3$* 14#1$3**
Hipang4 3 14*&'3** 14&('3**
Carreon4 M3 #*13"( (&"3**
Po!inar4 A3 14#')3"( $4$%)3**
+pina4 N3 14(**3"( $4("13**
Caada4 ;3 14")13"* $4$'$3**
5uiton4 ;3 "'(3'* 14#&'3**
Fernande,4 3 #1131' ))(3**
A!igato4;3 #'*3** ("*3**
A8ar-a4 3 ##$3*) ))13**
)(3$' a8agat4Y3 "&)3** "&*3**
""3)* Gautin4 +3 ##%3** #$%3**
)*31# C!eente4 63 "%13** "$'3**
1*%3%* 0antiane4 ;3 '$$3** )##3**
)13** 0i8aDan4 C3 )1*3** )**3**
)&3(1 Beri,o4 A3 14$'"3** 14$$)3**
11*3%* Miyu9i4 3 ''$3** '%(3**
&*311 Baynoa4 R3 )113** )*$3**
"(3%* Paon4 63 ##(3** ##$3**
)13"* 0er.i!!a4 C3 )1"3** )*"3**
'"3*( +!egin4 +3 )%13** )$"3**
)(3&* 5uinte4 03 )(&3** )'&3**
&$3** Buenafe4 3 %"*3** %'*3**
"*3$* Bet!agan4 H3 "*$3** ')$3**
7/25/2019 Statistical Treatment and Tables_SPC Research
27/27
%)3"* Mendo,a4 F3 $%#3** $##3**
1$(3%* Tagyaan4 H3 14##%3** 14#&%3**
")3** 6oDo4 @3 14$$%3** 14$()3**
"%3$% uaria4 W3 141**3** 141&*3**
(%3#& ?r8i,tondo4 3 14%)#3** 14')#3**
""3(* Aniue4 A3 14$&(3** 14#((3**
'$3$* Conrado4 B3 14"#13** 14"&13**)"31( Mag8anua4 P3 14#"(3** 14%*(3**
(*3($ Ba!a,ue!a4 F3 14%1"3** 14%&"3**
"&3($ Na.arro4 63 14$''3** 14$(#3**
(*3)* +todi!!o4 +3 14(")3** 14)")3**
")3#' Tero!4 R3 14&)$3** $4*$)3**
)13'' Ca!i8ay4 ;3 $"13** $)13**
"%3)' 0e-i8an4 R3 14##&3** 14%113**
"1311 Catana4 C3 14"*"3** 14"'"3**
'&3#$ Mag/aoano4 +3 "#(3** "'$3**